How a Common Oral Bacterium Quietly Drives Cancer Growth
Fusobacterium nucleatum has shifted from suspected bystander to confirmed cancer driver โ here's what the science reveals.
20 articles
Fusobacterium nucleatum has shifted from suspected bystander to confirmed cancer driver โ here's what the science reveals.
Bacteriophages transferred during FMT may drive horizontal gene transfer, altering microbial function and antibiotic resistance in ways science has largely ignored.
A landmark review maps the vaginal microbiome's role in infections and reproductive health, charting a path to precision probiotic therapies.
The British Society of Gastroenterology's expert panel takes stock of 10 years of microbiome advances and where the field is headed.
Age-related shifts in intestinal T cell populations may silently erode gut barrier function, accelerating the chronic inflammation that drives aging diseases.
A new review maps the bidirectional crosstalk between gut microbiota and cellular senescence driving multi-organ degeneration.
Aging disrupts gut microbiota and mTOR signaling, crippling vaccine responses โ but targeted interventions may reverse this.
A new review maps the structural and functional changes that help the bowel compensate after resection, and highlights where knowledge gaps remain.
A Cochrane meta-analysis of 17 RCTs finds amyloid-targeting antibodies offer minimal cognitive gains while significantly raising ARIA risk.
A landmark review reveals how diet, gut bacteria, and their metabolites determine the success of immune checkpoint blockade cancer therapy.
Senescent T cells fuel psoriasis, eczema, and rosacea through toxic secretions. New therapies may finally break the cycle.
A new Cell Metabolism review from NIH identifies how ECM stiffening, poor blood flow, and mitochondrial failure lock tissues into accelerating decline.
A landmark review argues neurodegeneration is driven by interacting misfolded proteins, not single culprits โ reshaping diagnosis and treatment.
New research reveals how people over 100 maintain youthful immune systems despite chronic inflammation, offering insights for healthy aging.
A new review links adult cholestasis to pediatric genetic syndromes, opening doors to targeted therapies including novel bile acid transport inhibitors.
A comparative review of NMN and NR supplements weighs tissue targeting, clinical evidence, and top-rated products for NAD+ optimization.
A Cochrane review of 107 RCTs finds vitamin D may slightly cut ARI-related doctor visits in under-5s, but evidence remains low-certainty.
A new perspective in Nature Cancer outlines how genetically engineered bacteria can target and destroy tumors from within.
New expert reviews compare NMN and NR head-to-head, ranking top products by purity, absorption, and clinical evidence.
Both NMN and NR raise NAD+ levels in humans, but clinical proof of anti-aging benefits is still lacking โ and product quality varies widely.